Chemotherapeutic drug delivery by tumoral extracellular matrix targeting
Open Access
- 1 March 2018
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 274, 1-8
Abstract
No abstract availableKeywords
Funding Information
- Radboud University Medical Center
This publication has 62 references indexed in Scilit:
- Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-Containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal CancerPLOS ONE, 2012
- The evolving concept of cancer and metastasis stem cellsJournal of Cell Biology, 2012
- The extracellular matrix: A dynamic niche in cancer progressionJournal of Cell Biology, 2012
- Tumor Endothelial CellsCold Spring Harbor Perspectives in Medicine, 2011
- The Evolution of Extracellular MatrixMolecular Biology of the Cell, 2010
- A pH/Enzyme-responsive tumor-specific delivery system for doxorubicinBiomaterials, 2010
- Peptide-Targeted Nanoglobular Gd-DOTA Monoamide Conjugates for Magnetic Resonance Cancer Molecular ImagingBiomacromolecules, 2010
- The Extracellular Matrix: Not Just Pretty FibrilsScience, 2009
- Antibody GD3G7 Selected against Embryonic Glycosaminoglycans Defines Chondroitin Sulfate-E Domains Highly Up-Regulated in Ovarian Cancer and Involved in Vascular Endothelial Growth Factor BindingThe American Journal of Pathology, 2007
- Intracellular drug delivery by sulfatide-mediated liposomes to gliomasJournal of Controlled Release, 2006